What Are Embryonic Stem Cells?
Embryonic stem (ES) cells are a collection of cells found only in very early development which are the precursors to every celltypein the human body. The vast majority of cells in the body (somatic cells) fall into specific classes or types, such as muscle, bone and neurons, each of which have unique characteristics and functions. However, these cells are not interchangeable(a muscle cell cannot become a neuron) and most of these cells have lost the ability to multiply to create new cells. ES cells differ from all other cells in two important ways. First, they can be induced tochange, or differentiate, into virtually any cell type. Second, unlike somatic cells which have finite lifespans, ES cell can grow indefinitely in culture. These two unique characteristics give ES cells enormous potential to medicine and science.
Embryonic stem cells are important to medicine because of their ability to change into other cell types. This ability means that ES cells have the potential to repair damaged organs and replace cells that do not function properly. Since they can multiply indefinitely, the large numbers of cells necessary to repair or replace these tissues can be produced. Thus, the hope is that ES cells can be a renewable source of replacement cells that can be used to treat a number of medical problems including Parkinson's and Alzheimer's disease, strokes, burns, spinal cord damage and heart disease.
Recent publications have described the derivation of ES-like induced pluripotent stem (iPS) cells from adult mouse and human cells(Nakagawa et al., 2008;Takahashi et al., 2007;Yu et al., 2007). These researchers introduced specific sets of genes encoding transcription factors which are normally expressed in undifferentiated ES cells. The expression of these genes resulted in thereprogramming of the adult cells to a more ES-like or pluripotent state. While the initial studies indicate that these cells share characteristics of true ES cells, more detailed work is needed to determine how closely they resemble ES cells. In addition, the reintroduction of these genes can have adverse consequences. For instance, the use of retroviruses and the potential for reactivation of introduced genes such as c-myc and Oct-4 can increase the risk of cancer. These issues will need to be addressed if iPS technology will have clinical applications.
The human body has a relatively small number of cells, called adult stem cells that are capable of differentiating into a limited range of cell types. For instance, blood stem cells are capable of changing into a number or different types of blood cells. These adult ES are also of enormous importance to medicine. However, they have limitations that ES cells do not. First, they are limited in the number of types of cells into which they can change. For instance, blood stem cells cannot form bone. In addition, unlike ES cells adult stem cells do not appear to have the same capacity to multiply indefinitely. They have also been more difficult to grow in the laboratory. So, while adult stem cells are important, they cannot be viewed at this time as a replacement for ES cells. Research into all types of stem cells is needed in order to advance medicines ability to treat disease.
Types of Stem Cells
hES Cells
SCNT ES Cells
iPS Cells
Adult Stem Cells
Derivation Method
Removal of cells from ICM of blastocyst embryo from IVF.
Somatic Cell Nuclear Transfer. Transfer of somatic cell nucleus to enucleated egg, development to blastocyst, removal of ICM.
Reprogramming of somatic cells by introduction of specific regulatory factor genes.
Isolation from adult tissues.
Characteristics
Differentiate into all cell types.
Excess of IVF embryos exist.
Differentiate into all cell types.
Stem cells can be matched to patient
ES cell like characteristics.
Stem cells can be matched to patient
Doesn't require embryos.
Successful treatments demonstrated.
Stem cells can be matched to patient
Limitations
Limited number of lines available for federally funded research.
Immune rejection issues
Risk of tumors (teratomas) from transplanting undifferentiated cells.
Requires use of embryo.
Risk of tumors (teratomas) from transplanting undifferentiated cells.
Eggs difficult to obtain.
Unknown if cells can differentiate into all cell types.
Risk of tumors (teratomas) from transplanting undifferentiated cells and from expression of introduced genes.
Cells not found in all tissues.
Produce a limited number of cell types.
Difficult to identify, isolate and grow.
Top
Stem Cell Basics Prepared by the National Institutes of Health, this primer on stem cells answers a number of fundamental questions about the properties and potential uses of embryonic and adult stem cells with a glossary of terms and illustrations.
Tell Me About Stem Cells This site, created by Harvard and MIT, provides basic information about stem cells in plain language with illustrations.
Understanding Stem Cells Developed and published by the National Academy of Sciences, this free booklet (available as a 1.13 MB PDF, 24 pages) provides information on what stem cells are and why stem cell research is important, as well as the ethical and legal issues surrounding stem cells.
EuroStemCell This website presents information and educational resources about stem cells from a European perspective.
National Institutes of Health Stem Cell FAQs This page contains a wealth of information, from basic questions about stem cells, to research and potential clinical uses of stem cells as well as US government policies.
ISSCR Stem Cell FAQs Prepared by the International Society for Stem Cell Research, this page addresses a number of basic questions about embryonic and adult stem cells, their origins and potential uses.
MedlinePlus: Stem Cells This site offers a number of useful links for those seeking health-related information about embryonic and adult stem cells; from basic information to disease specific sites to links to clinical trials.
A Closer Look at Stem Cell Treatments This site is designed to arm patients, their families and doctors with information they need to make decisions about stem cell treatments. The content of this site is based on recommendations from the ISSCR's Task Force on Unproven Stem Cell Treatments.
21st Century Snake Oil A CBS 60 minutes story from 2010 that serves as a warning about unscrupulous stem cell therapies.
Top
Read the original here:
Stem Cell Facts - University of Massachusetts Medical School
- Heres How Fasting Benefits Your Mental and Physical Wellbeing - News18 - October 4th, 2022
- Asymmetrex Gives First Cell Culture Core Facility Introduction to Online Rapid Stem Cell Counting in the Institute for Applied Life Sciences at... - September 25th, 2022
- Asymmetrex's Introduction of Online Calculators for Determination of the Dosage of Therapeutic Stem Cells Announced as a Reformation in Stem Cell... - September 16th, 2022
- UMass Dartmouth awarded $750000 Massachusetts Life Science grant to diversify the field - New Bedford Guide - September 16th, 2022
- ALS Thought Leaders Weigh in Ahead of Second Amylyx Adcomm - BioSpace - September 8th, 2022
- Scientists convert kidney to universal O blood type - Freethink - August 30th, 2022
- Case Study: SARS-CoV-2 Virus Infecting the Inner Ear - Victoria News - August 14th, 2022
- Evidence Is Growing That LSD Improves Learning and Memory - Futurism - August 14th, 2022
- Rice University: Rice, Baylor developing implants to heal heart attack injuries | India Education | Latest Education News | Global Educational News |... - August 14th, 2022
- Iconic everyday inventions and the women behind them - YourStory - August 14th, 2022
- Head to Head Analysis: VolitionRx (NYSE:VNRX) vs. Intellia Therapeutics (NASDAQ:NTLA) - Defense World - August 14th, 2022
- Man who saved life as stem cell donor urges others to help his friend find a match after five-year search - Lancashire Evening Post - August 5th, 2022
- The 3D Cell Culture Market is expected to reach a value of USD 3721.86 Million by 2027, at a CAGR of 13.4% (2021 2027) - Digital Journal - August 5th, 2022
- Flow Cytometry Market is expected to reach a value of USD 11467.80 Million by 2027, at a CAGR of 8.88% over the forecast period (2021 2027) - Digital... - July 27th, 2022
- Stem Cells Market Competitive Insights And Global Outlook 2022 To 2027 Vcanbio, Boyalife, Beikebiotech, Thermo Fisher Scientific (Massachusetts, US),... - July 11th, 2022
- Seven UMass Amherst Faculty Members Receive NSF CAREER Awards in 2021-22 Academic Year - UMass News and Media Relations - July 11th, 2022
- BrainStorm Strengthens Executive Team with Key Appointments in R&D and Legal - GuruFocus.com - June 22nd, 2022
- Asymmetrex Presents New Developments in its Rapid Stem Cell Counting Technology at the ARMI|BioFabUSA Meeting in the Millyard on Regenerative Medicine... - June 13th, 2022
- Investigators Seek to Push Combination Therapy to the Front-line Treatment of aGVHD - OncLive - June 4th, 2022
- Stem Cells Market 2022 Industry Analysis, Segmentation, Share, Size, Opportunities and Forecast to 2027 The Greater Binghamton Business Journal - The... - June 4th, 2022
- Sheldon Krimsky, Who Warned of Profit Motive in Science, Dies at 80 - The New York Times - May 15th, 2022
- We met during cancer treatments, fell in love and got married - New York Post - May 15th, 2022
- Ticking time bombs of DNA mutation may dictate when animals die - Livescience.com - May 2nd, 2022
- Sen. Orrin Hatch's legacy tracks the GOP's evolution on health - Wisconsin Public Radio - May 2nd, 2022
- Emerging interactions between skin stem cells and their ... - April 6th, 2022
- Priothera Receives R&D Innovation Loan from Bpifrance - PR Newswire - April 6th, 2022
- What is Regeneration? review: A dive into the science of regrowth - New Scientist - April 6th, 2022
- 5 FDA decisions to watch in the second quarter - BioPharma Dive - April 6th, 2022
- Takeda and the New York Academy of Sciences Announce 2022 Innovators in Science Award Winners - The New York Academy of Sciences - April 6th, 2022
- MorphoSys and Incyte Announce Swissmedic Temporary Approval of Minjuvi(R) (tafasitamab) in Combination with Lenalidomide for the Treatment of Adults... - March 25th, 2022
- January 2022: 2021 Papers of the year - Environmental Factor Newsletter - January 5th, 2022
- Liso-Cel Outperforms Standard Therapy in Improving QoL in Relapsed/Refractory LBCL - www.oncnursingnews.com/ - January 5th, 2022
- Stem cells: Sources, types, and uses - Medical News Today - December 24th, 2021
- cGVHD Paradigm Gains Systemic Options Beyond Steroids, But Real-World Data Are Required - OncLive - October 28th, 2021
- Asymmetrex Will Present a New Test for Therapeutic Stem Cell Potency at the ISSCR 2021 Annual Meeting - PRNewswire - June 23rd, 2021
- Infertility: Men account for at least half of cases. So why have women shouldered the blame? - The Irish Times - June 23rd, 2021
- On systemic sources of early life stress, and empathetic responses - MIT News - June 6th, 2021
- How Coronavirus Damages Lung Cells Within Mere Hours And What Drugs Could Halt COVID-19 Infection - SciTechDaily - February 1st, 2021
- Orchard Therapeutics Outlines Comprehensive Presence at 2021 WORLDSymposium - GlobeNewswire - February 1st, 2021
- NurOwn May Be Given to Early ALS Patients in US Who Finished Phase... - ALS News Today - December 20th, 2020
- Be Biopharma debuts with $52M to advance engineered B-cell therapies - FierceBiotech - October 24th, 2020
- Targeted Therapy for Non-Hodgkin Lymphoma: Current Progress and Future Plans - Cancer Therapy Advisor - September 5th, 2020
- Massachusetts Eye and Ear Enters Licensing Agreement with Biogen to Develop Treatment for Inherited Retinal Disorder - Newswise - July 2nd, 2020
- Startup targets glioblastoma tumors with CAR-T therapy - FierceBiotech - May 28th, 2020
- Infrared Laser Treatment of TBI, PTSD, and Depression: An Expert Perspective - Psychiatry Advisor - April 3rd, 2020
- 10 Of The Biggest World Revelations In The 21st Century - World Atlas - February 29th, 2020
- Where Are They Now? Top 3 Biotech Startups From NextGen Bio Class of 2018 - BioSpace - January 10th, 2020
- Firm adds a new wrinkle to anti-aging products - Williamson Daily News - January 5th, 2020
- Top Emerging Technologies of the Year - Technowize - December 29th, 2019
- New Podcast Sponsored by Asymmetrex Increases Awareness to the Need for Stem Cell Dose in Stem Cell Treatments - PR Web - November 9th, 2019
- Exercise found to block chronic inflammation in mice - Harvard Gazette - November 9th, 2019
- Arkuda bags $44M to target progranulin and head off inherited dementia - FierceBiotech - November 9th, 2019
- New study reveals why breast cancer spreads to the brain - USC News - October 23rd, 2019
- Comparison of Merus N.V. (MRUS) and Sage Therapeutics Inc. (NASDAQ:SAGE) - MS Wkly - October 23rd, 2019
- Reviewing Cellectis S.A. (CLLS)'s and Magenta Therapeutics Inc. (NASDAQ:MGTA)'s results - MS Wkly - October 23rd, 2019
- Massachusetts Stem Cells | Stem Cell TV - September 10th, 2019
- Chronic variable stress activates hematopoietic stem cells ... - April 12th, 2019
- Boston, MA, Stem Cell Transplant, Weston, Nantucket ... - January 10th, 2019
- Cloning/Embryonic Stem Cells - National Human Genome ... - July 5th, 2018
- Alternate Methods for Preparing Pluripotent Stem Cells ... - September 25th, 2017
- Doubts raised about CRISPR gene-editing study in human embryos - Nature.com - September 2nd, 2017
- For Lowell native, stem cell match becomes a match as friends - Lowell Sun - September 2nd, 2017
- Lymphoma Patient's Brain Tumor Disappeared After She Received JCAR017, Study Reports - Lymphoma News Today - September 2nd, 2017
- Asymmetrex Introduces New Contract Service For Producing ... - PR Web (press release) - August 29th, 2017
- ORGANOID - Science Magazine - August 27th, 2017
- Current humanized mice not good models for studying stem cell transplants, say researchers - Scope (blog) - August 27th, 2017
- Mouse Model of Human Immune System Inadequate for Stem Cell ... - Technology Networks - August 27th, 2017
- CRISPR fixes disease gene in viable human embryos - Nature.com - August 6th, 2017
- X4 joins hands with Yale on rare disease program - FierceBiotech - August 6th, 2017
- TGF-1: ALS Astrocytes' Secret Sauce? - ALS Research Forum - August 6th, 2017
- From Stem Cells to Human Development - September 2016 ... - December 4th, 2016
- Stem cell controversy - Wikipedia - December 1st, 2016
- What Are Stem Cells? - Massachusetts General Hospital ... - November 22nd, 2016
- New England Cord Blood Bank - Cord Blood and Cord Tissue ... - November 22nd, 2016
- Stem-cell-based therapy promising for treatment of breast ... - September 26th, 2016
- Stem Cell FAQ - Massachusetts General Hospital, Boston, MA - July 27th, 2016
- Scientists engineer toxin-secreting stem cells to treat ... - October 19th, 2015
- Cloning/Embryonic Stem Cells - Genome.gov - October 19th, 2015
- Biomedical engineer developing nanomaterial for healing broken bones - March 18th, 2015
- Researchers identify a vital protein that can determine head and brain development - March 13th, 2015